ClinicalTrials.Veeva

Menu

CHACO Study: Control of Arterial Hypertension in Colombian Patients

S

Scandinavia Pharma

Status

Enrolling

Conditions

Hypertension

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

Full description

OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

MATERIALS AND METHODS: Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in "mono-tablet" versus "multi-tablet". The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.

Enrollment

1,100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Prior diagnosis of Arterial Hypertension (AH) ≥ 3 months before
  • Patients who are under pharmacological treatment of AH ≥ 3 months before

Exclusion criteria

  • The patient has rejected the participation in the study.
  • Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer the questions.
  • Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.

Trial contacts and locations

1

Loading...

Central trial contact

Javier Castillo, Dr; Ferrari Claudio, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems